Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Anti-Cancer Drugs
|
October 11, 2003
Imatinib mesylate (STI571; Glivec)--a new approach in the treatment of biliary tract cancer?
Marcus Wiedmann, Florian Kreth, Jürgen Feisthammel, et al.
Leukemia Research
|
February 5, 2011
Changes in the activity of the GPx-1 anti-oxidant selenoenzyme in mononuclear cells following imatinib treatment
Emily N Terry, Peter H Gann, Robert Molokie, et al.
Journal of Cancer Research and Clinical Oncology
|
March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
Verena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Blood
|
August 1, 2015
The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis
Michael Deininger, Jerald Radich, Timothy C Burn, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 13, 2003
No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec)
Paul La Rosée, Lei Shen, Eric P Stoffregen, et al.
Research in Engineering Design
|
September 1, 2020
Prototyping for context: exploring stakeholder feedback based on prototype type, stakeholder group and question type
Michael Deininger, Shanna R Daly, Jennifer C Lee, et al.
International Journal of Hematologic Oncology
|
October 2, 2020
Pregnancy outcomes in patients treated with bosutinib
Jorge E Cortes, Carlo Gambacorti-Passerini, Michael Deininger, et al.
Leukemia
|
June 11, 2010
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Thomas Bumm, Jutta Deininger, Amy Hanlon Newell, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
June 27, 2019
Design and evaluation of a subcutaneous contraceptive implant training simulator
Samuel K K Dery, Elsie E Kaufmann, David Marzano, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Cross-Species Morphology Learning Enables Nucleic Acid-Independent Detection of Live Mutant Blood Cells
Sarmad Ahmad Khan, Dominik Faerber, Danielle Kirkey, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Anti-Cancer Drugs
|
October 11, 2003
Imatinib mesylate (STI571; Glivec)--a new approach in the treatment of biliary tract cancer?
Marcus Wiedmann, Florian Kreth, Jürgen Feisthammel, et al.
Leukemia Research
|
February 5, 2011
Changes in the activity of the GPx-1 anti-oxidant selenoenzyme in mononuclear cells following imatinib treatment
Emily N Terry, Peter H Gann, Robert Molokie, et al.
Journal of Cancer Research and Clinical Oncology
|
March 10, 2017
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
Verena S Hoffmann, Joerg Hasford, Michael Deininger, et al.
Blood
|
August 1, 2015
The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis
Michael Deininger, Jerald Radich, Timothy C Burn, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 13, 2003
No correlation between the proliferative status of Bcr-Abl positive cell lines and the proapoptotic activity of imatinib mesylate (Gleevec/Glivec)
Paul La Rosée, Lei Shen, Eric P Stoffregen, et al.
Research in Engineering Design
|
September 1, 2020
Prototyping for context: exploring stakeholder feedback based on prototype type, stakeholder group and question type
Michael Deininger, Shanna R Daly, Jennifer C Lee, et al.
International Journal of Hematologic Oncology
|
October 2, 2020
Pregnancy outcomes in patients treated with bosutinib
Jorge E Cortes, Carlo Gambacorti-Passerini, Michael Deininger, et al.
Leukemia
|
June 11, 2010
Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors
Thomas Bumm, Jutta Deininger, Amy Hanlon Newell, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
June 27, 2019
Design and evaluation of a subcutaneous contraceptive implant training simulator
Samuel K K Dery, Elsie E Kaufmann, David Marzano, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Cross-Species Morphology Learning Enables Nucleic Acid-Independent Detection of Live Mutant Blood Cells
Sarmad Ahmad Khan, Dominik Faerber, Danielle Kirkey, et al.
Page
of 8